ZuriMED Technologies AG

ZuriMED Technologies AG is a Swiss medical technology company based in Zurich, founded in 2015 as a spin-off from the Institute for Biomechanics at ETH Zurich and the University of Zurich. The company focuses on developing advanced technologies for soft tissue repair, particularly in orthopedic sports medicine, with the goal of enhancing surgical outcomes and improving patient quality of life. ZuriMED's flagship product is the FiberLocker® System, designed to augment rotator cuff repair procedures. This innovative technology has received FDA 510(k) clearance, facilitating its clinical adoption. The company collaborates closely with leading universities and healthcare institutions, such as Balgrist University Hospital, to translate research innovations into practical solutions for surgeons and patients. With a small team of fewer than 25 employees, ZuriMED is committed to fostering a culture of innovation and collaboration. The company aims to redefine surgical practices and improve treatment options for healthcare professionals specializing in orthopedic surgery and sports medicine.

• Employees 32
• Founded 2015
• Annual Revenue $5703000
• Total Funding $16605295